Clinical Diagnostics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
32
NCT02133807
Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis
Phase: Phase 3
Role: Collaborator
Start: Sep 30, 2009
Completion: Jun 30, 2012
Loading map...